Abstract:Introduction: There remains a pressing need for a suitable alternative to currently available techniques for tissue engineering. the use of pluripotent stem cells for tissue engineering has thus far required a period of ex vivo differentiation prior to in vivo implantation to avoid the formation of a teratoma. in this study, we set out to differentiate pluripotent cells down an osteogenic lineage in vivo without pre-differentiation through the creation of a novel osteogenic niche. Methods: Human induced pluripotent stem cells (h-iPS) were derived from human adipose-derived stromal cell using the four Yamanaka factors and characterized for pluripotency. Human embryonic stem cells (hESC) were obtained from existing federally mandated cell lines. The ability of h-iPS and hESC to differentiate down an osteogenic lineage was confirmed in vitro through q-PCR, western blotting, and immunocytochemistry. h-iPS and hESC cells were seeded onto an osteogenic micro-niche consisting of a hydroxyapatite-coated osteoinductive scaffold with BMP-2 and implanted into a 4mm critical-sized calvarial defect macro-niche without prior ex-vivo differentiation in athymic mice. Implanted cell viability was followed through bioluminescence and histological analysis using human nuclear antigen. in vivo calvarial defect healing was assessed by microCT and histology. Results: We demonstrate that the implanted h-iPS and hESC cells undergo teratoma formation when placed in vivo either subcutaneously or within the renal capsule. We show that these cells can undergo osteogenic differentiation in vitro, as revealed by an up-regulation of alkaline phosphatase activity, mineralization and numerous gene markers (RUNX2, OCN and ALP) when placed in osteogenic medium. Most importantly, we also demonstrate that pluripotent cells seeded on an osteoconductive scaffold survive and participate in de novo bone formation, contribute to the healing of skeletal defects, and do not form a teratoma as defined by calcification on Micro CT and histological analysis. Conclusions: These data support that an osteogenic micro-niche scaffold placed into a macro-environmental niche of a skeletal defect promotes in vivo-directed pluripotent cell osteogenic differentiation without the formation of a teratoma. We believe this is the first example of directed lineage differentiation of pluripotent cells without teratoma formation in vivo and without a period of ex-vivo pre-differentation. Development of an in vivo model for directed differentiation of pluripotent cells would be important for these cells as we move closer to clinical applications.

In Vivo Human Somitogenesis Guides Somite Development from hPSCs

Efficient Derivation of Lateral Plate and Paraxial Mesoderm Subtypes from Human Embryonic Stem Cells Through GSKi-Mediated Differentiation

A Comparison of Murine Smooth Muscle Cells Generated from Embryonic Versus Induced Pluripotent Stem Cells

Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells

Single Cell Transcriptomics-informed Induced Pluripotent Stem Cells Differentiation to Tenogenic Lineage

Directed Differentiation of Human Pluripotent Stem Cells toward Skeletal Myogenic Progenitors and Their Purification Using Surface Markers

Generation of Skeletal Muscle Organoids from Human Pluripotent Stem Cells

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

Diverse Routes toward Early Somites in the Mouse Embryo

Identification of novel evolutionarily conserved genes and pathways in human and mouse musculoskeletal progenitors

Regeneration of the human segmentation clock in somitoids in vitro

Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors

Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types

Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development

Controlled Modelling of Human Epiblast and Amnion Development Using Stem Cells.

ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs

Mapping molecular landmarks of human skeletal ontogeny and pluripotent stem cell-derived articular chondrocytes

In Vivo Directed Differentiation Of Pluripotent Stem Cells For Skeletal Regeneration

Human Germ Cell Differentiation from Fetal- and Adult-Derived Induced Pluripotent Stem Cells

Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses

In Vivo Directed Differentiation of Pluripotent Stem Cells to Bone Lineage and Repair of a Skeletal Defect